ANI Pharmaceuticals (ANIP)
Develops rare-disease therapies, niche generics, and established prescription brands.
$77.91
After hours0.00 (0.00%)
At close$77.91(−1.19%)
Something off on this page? Send us feedback.
Next report
Nov 6, 26
in 45 days
EPS estimate
$2.12
Revenue estimate
$280.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.63$1.70$1.80$2.04$2.33$2.05$2.21Pending
Estimate$1.41$1.37$1.38$1.74$1.99$1.28$2.04$2.12
Surprise+15.6%+24.1%+30.4%+17.2%+17.1%+60.2%+8.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$190.6M$197.1M$211.4M$227.8M$247.1M$237.5M$266.0MPending
Estimate$170.0M$188.7M$208.8M$232.2M$231.1M$207.6M$260.1M$280.1M
Surprise+12.1%+4.4%+1.2%−1.9%+6.9%+14.4%+2.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $3.12 | — | — |
| Sep 2028 | $2.95 | — | — |
| Jun 2028 | $2.93 | — | — |
| Mar 2028 | $2.58 | — | — |
| Dec 2027 | $3.48 | — | — |
| Sep 2027 | $2.84 | — | — |
| Jun 2027 | $2.52 | — | — |
| Mar 2027 | $1.87 | — | — |
| Dec 2026 | $2.86 | — | — |
| Nov 2026 | $2.12 | — | — |
| Aug 2026 | $2.04 | $2.21 | +8.3% |
| May 2026 | $1.28 | $2.05 | +60.2% |
| Feb 2026 | $1.99 | $2.33 | +17.1% |
| Nov 2025 | $1.74 | $2.04 | +17.2% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $3.12 | — | — | $377.0M | — | — | — |
| Sep 2028 | $2.95 | — | — | $355.8M | — | — | — |
| Jun 2028 | $2.93 | — | — | $339.8M | — | — | — |
| Mar 2028 | $2.58 | — | — | $317.6M | — | — | — |
| Dec 2027 | $3.48 | — | — | $360.8M | — | — | — |
| Sep 2027 | $2.84 | — | — | $327.2M | — | — | — |
| Jun 2027 | $2.52 | — | — | $305.1M | — | — | — |
| Mar 2027 | $1.87 | — | — | $264.8M | — | — | — |
| Dec 2026 | $2.86 | — | — | $319.4M | — | — | — |
| Nov 6, 2026 | $2.12 | — | — | $280.1M | — | — | — |
| Aug 7, 2026 | $2.04 | $2.21 | +8.3% | $260.1M | $266.0M | +2.3% | −5.3% |
| May 8, 2026 | $1.28 | $2.05 | +60.2% | $207.6M | $237.5M | +14.4% | −2.4% |
| Feb 27, 2026 | $1.99 | $2.33 | +17.1% | $231.1M | $247.1M | +6.9% | −4.2% |
| Nov 7, 2025 | $1.74 | $2.04 | +17.2% | $232.2M | $227.8M | −1.9% | +0.2% |
| Aug 8, 2025 | |||||||
| May 9, 2025 | |||||||
| Feb 28, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 10, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 1, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 7, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 4, 2017 | |||||||
| Mar 2, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 23, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 4, 2015 |